The Interactions of T Cells with Myeloid-Derived Suppressor Cells in Peripheral Blood Stem Cell Grafts
The interaction of myeloid-derived suppressor cells (MDSCs) with T cells within G-CSF-mobilized peripheral blood stem cell (PBSC) grafts in patients undergoing autologous or allogeneic hematopoietic stem cell transplantation remains to be elucidated. Through studying allo- and auto-PBSC grafts, we observed grafts containing large numbers of T cells and MDSCs with intergraft variability in their percentage and number. T cells from autologous grafts compared to allografts expressed relative higher percentages of inhibitory receptors PD-1, CTLA-4, TIM-3, LAG-3, TIGIT and BTLA. Autograft T cells had decreased cell proliferation and IFN-γ secretion, which supported the possible presence of T cell exhaustion. On the contrary, graft monocytic MDSCs (M-MDSCs) expressed multiple inhibitory receptor ligands, including PD-L1, CD86, Galectin-9, HVEM and CD155. The expression of inhibitory receptor ligands on M-MDSCs was correlated with their corresponding inhibitory receptors on T cells in the grafts. Isolated M-MDSCs had the ability to suppress T cell proliferation and IFN-γ secretion and/or promote Treg expansion. Blocking the PD-L1-PD-1 signaling pathway partially reversed the functions of M-MDSCs. Taken together, our data indicated that T cells and M-MDSCs in PBSC grafts express complementary inhibitory receptor-ligand pairing, which may impact the quality of immune recovery and clinical outcome post transplantation.
Authors
- Donna A. Wall (ORCID: https://orcid.org/0000-0002-5442-5536)
- Qingdong Guan (ORCID: https://orcid.org/0000-0003-1972-487X)
- J. Ray Doerksen
- Scott Gilpin
- Lauren Bath
- Pascal Lambert (ORCID: https://orcid.org/0000-0003-2126-7591)
- Yun Li (ORCID: https://orcid.org/0000-0001-6276-9104)
- Tracy Lam
Institutions
- Research Manitoba (CA)
- CancerCare Manitoba (CA)
- Research Institute in Oncology and Hematology (CA)
- University of Manitoba (CA)
Publication Details
- Journal
- Cells
- Published
- 2024-09-14
- DOI
- https://doi.org/10.3390/cells13181545
- Citations
- 5
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.20
Funders
- CancerCare Manitoba Foundation
- Multiple Sclerosis Society of Canada